Ebola vaccines stockpiled against future outbreaks

January 12, 2021 04:53 pm | Updated 04:53 pm IST - Geneva

File photo for representation.

File photo for representation.

The World Health Organisation and partners said on Tuesday they are creating a global stockpile of Ebola vaccines to help stamp out future outbreaks.

In a statement, WHO, Doctors Without Borders, UNICEF and the International Federation of Red Cross and Red Crescent Societies said they were establishing an emergency reserve of about 500,000 doses; nearly 7,000 are available now and more will be added throughout the year and beyond. Financial support for the vaccine stockpile was provided by the vaccines alliance GAVI.

The Ebola vaccine being stockpiled is made by Merck. Before it was licensed, the shot was used to previously help contain outbreaks in Guinea and Congo under a protocol for “compassionate use.” Other stockpiles managed by WHO and partners exist for diseases including meningitis and yellow fever.

The Ebola vaccines will be stored in Switzerland, where they will be ready to be shipped after WHO and partners receive a request from countries. The agencies say any decision to release vaccines will be made within 48 hours of any such request and that the targeted delivery time is within one week.

The vaccines will be reserved for those at highest risk of being infected with Ebola during any epidemic, including those exposed to the disease and health workers treating patients and their contacts.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.